ERN1 and alveolar rhabdomyosarcoma: These results suggest that the IRE1α arm of UPR is more profoundly associated with aggressiveness and the progression of the disease, which further confirms that the targeting of IRE1α could be considered for the treatment of RMS, especially ARMS.